Jefferies maintained a Buy rating on Olaplex Holdings, Inc. (OLPX) on March 4, 2026, while lowering its price target to $16.25. The OLPX analyst rating update signals continued conviction in the company’s long-term recovery story despite nearer-term pressure. Jefferies kept the Buy stance after trimming forward expectations, a move that matters for investors monitoring analyst support and price guidance. The firm also noted a 7.88% change since its prior note, listed as $0.13 in the published summary.

OLPX analyst rating: Jefferies action and details

On March 04, 2026 Jefferies maintained Buy on Olaplex (OLPX) and cut its price target to $16.25, according to StreetInsider reporting. The published note lists a 7.88% move measured as $0.13 since the prior data point. Full details are in the Jefferies write-up on StreetInsider source.

OLPX analyst rating meaning for investors

A maintained Buy with a lower price target means analysts still see upside but expect slower near-term earnings or slower recovery in margins. For investors, the note suggests holding conviction if you have a multi-quarter horizon and watching quarterly results for evidence of margin stabilization.

OLPX analyst rating in historical context

Jefferies has been among the recurring brokers covering Olaplex; recent activity shows the firm keeping a constructive stance while trimming forecasts. Historically OLPX coverage has shifted between Positive and Cautious as the company reset distribution and margins, and this March 2026 note continues that pattern.

OLPX analyst rating and stock performance link

Analyst moves often influence short-term flows; a maintained Buy with a lower target can calm selling pressure but not spark fresh rallies. Olaplex’s market cap is $1,188,171,191, and investors should compare the $16.25 target to the current market price and volatility before adjusting positions.

OLPX analyst rating risks and catalysts

Key upside catalysts include accelerating retail sell-through, margin recovery, and positive distributor updates, while downside risks include slower demand and margin pressure. Related industry news, such as Interparfums’ global brand expansion, may influence sector comparisons and is detailed by Seeking Alpha source.

Meyka view and proprietary grade for OLPX analyst rating

Meyka AI rates OLPX with a grade of B. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Our AI-powered market analysis platform tracks the Jefferies note and places the update in the context of broader coverage and price-target trajectories; grades are not guarantees and are not financial advice. For live quotes and model outputs visit the Meyka OLPX page Meyka OLPX page.

Final Thoughts

Jefferies’ March 4, 2026 note keeps a Buy on Olaplex (OLPX) while lowering the price target to $16.25, a sign the firm still sees recovery potential but expects slower near-term progress. The OLPX analyst rating therefore signals durable analyst support but reduced upside from prior targets, so investors should weigh time horizon and risk tolerance before acting. Given Olaplex’s $1,188,171,191 market cap and mixed near-term indicators, active investors may prefer to wait for clearer sales and margin signs, while longer-term holders may view the maintained Buy as confirmation of the turnaround thesis. Remember, Meyka AI rates OLPX with a grade of B, which reflects relative strength versus benchmarks, sector posture, growth metrics, and consensus analyst views and is not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.